Kistler-Tiffany Companies’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-157
Closed -$3.71K 819
2022
Q4
$3.71K Buy
157
+100
+175% +$2.7K ﹤0.01% 704
2022
Q3
$1K Hold
57
﹤0.01% 765
2022
Q2
$2K Hold
57
﹤0.01% 720
2022
Q1
$4K Sell
57
-223
-80% -$16.1K ﹤0.01% 679
2021
Q4
$26K Hold
280
0.01% 461
2021
Q3
$36K Hold
280
0.01% 411
2021
Q2
$47K Hold
280
0.01% 371
2021
Q1
$51K Hold
280
0.01% 333
2020
Q4
$56K Buy
280
+48
+21% +$9.76K 0.02% 288
2020
Q3
$51K Hold
232
0.02% 269
2020
Q2
$44K Sell
232
-87
-27% -$15.2K 0.02% 266
2020
Q1
$27K Hold
319
0.01% 328
2019
Q4
$27K Hold
319
0.01% 335
2019
Q3
$22K Buy
+319
New +$21K 0.01% 355

Other funds holding TDOC

Kistler-Tiffany Companies's TDOC Position: Q1 2023 in Review

Kistler-Tiffany Companies sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 157 shares — an estimated $3.71K sold.

Kistler-Tiffany Companies first reported a position in TDOC in Q3 2019 and held it in 14 quarters. The position peaked at $56K in Q4 2020. 430 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

  • Kistler-Tiffany Companies reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 157 Teladoc Health shares in Q1 2023, an estimated $3.71K.
  • Kistler-Tiffany Companies first reported a position in Teladoc Health in Q3 2019 and held it in 14 quarters.
  • Kistler-Tiffany Companies's Teladoc Health position peaked at $56K in Q4 2020.
  • 430 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q1 2023, filed 3 May 2023.